GHRS
GH Research PLC Ordinary SharesRecent alerts on GHRS
All signals →
SEC filing
GHRS Reports Phase 2b Trial Results: GH001 Shows -2.00 Cohen's d Reduction in MADRS Anhedonia Factor Scores vs Placebo at Day 8
12d ago
News
GH Research GAAP EPS of -$0.31
19d ago
SEC filing
GHRS Posts $18.97M Q1 Loss, $0.31 EPS, $142M Cash Boost from $150M Share Issue
19d ago
News
GH Research prices $117.5M share offering
34d ago
News
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
43d ago
News
Psychedelic stocks rally after Trump orders faster PTSD research; Compass Pathways, Atai lead gains
43d ago
SEC filing
GHRS Reports $280.7M Cash, $48.3M Net Loss, +$38.8M R&D, Phase 2b MADRS -15.5, 57.5% Remission, FDA Alignment Target 2026
89d ago
News
GH Research surges as FDA lifts clinical hold on depression therapy
148d ago
News
Stock Market Today: S&P 500, Nasdaq Futures Rise, WTI Fluctuates Following US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus
148d ago
News
GH Research surges on upcoming late-stage trial update
150d ago
News
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
153d ago
Scanner
Unusual volume (z=4.1)
160d ago
Scanner
Unusual volume (z=4.3)
161d ago
Scanner
Unusual volume (z=4.3)
163d ago
Scanner
Unusual volume (z=4.3)
164d ago
Get push alerts for GHRS
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS